Satellite Symposium at the European League Against Rheumatism (EULAR) congress
Thursday, June 14, 2018, 08:15–09:45
Hall 3, RAI Amsterdam, Amsterdam, the Netherlands
| Time | Title | Speaker |
|---|---|---|
| 08:15–08:30 | Welcome and introduction Transforming treatments: How TNF inhibitors led the field in the biologic revolution | Ferry Breedveld, MD, PhD Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands |
| 08:30–08:45 | Transforming standards: Treat to target and the PASSIONate revolution | Boulos Haraoui, MD Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada |
| 08:45–09:05 | Transforming outcomes: The role of patients in assessing their own disease | Wouter Bos, MD, PhD Department of Rheumatology, Reade, Amsterdam, the Netherlands |
| 09:05–09:25 | Transforming targets: Drug discovery and development | Lisa Olson, PhD Vice President, Discovery Immunology & AbbVie Bioresearch Center Site Head, Worcester, MA, USA |
| 09:25–09:45 | Panel discussion and Q&A | All |
Zinc code: NL/HUM/0318/0151e
Date of preparation: May 2018